Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

<ul><li>Ascelia’s two most important value drivers are the US submission, which is now de-risked, and Ascelia is expecting a submission in early September.</li><li>The second critical value driver is to secure a US partner for the upcoming launch.</li></ul>

Ascelia’s two most important value drivers are the US submission, which is now de-risked, and Ascelia is expecting a submission in early September.The second critical value driver is to secure a US partner for the upcoming launch.

Ascelia Pharma: Just about to submit Orviglance for US approval